Cognitive reserve in multiple sclerosis: Protective effects of education
Ana Silva(Alnylam Pharmaceuticals (United States)), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Andreia Bettencourt(Universidade do Porto), Alexandra Gonçalves(Universidade do Porto), Cláudia Camila Dias(Universidade do Porto), Armando Teixeira‐Pinto(The University of Sydney), Cláudia Pinto(Universidade do Porto), Raquel Samões(Universidade do Porto), Ernestina Santos(Universidade do Porto), Sara Cavaco(Centro Hospitalar do Porto), Estér Coutinho(Universidade Católica Portuguesa), Inês Moreira, Berta Martins da Silva(Universidade do Porto)
Cited by 100
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k